• Silo Pharma’s wholly owned AI unit QwikAgents engaged Caylent, an AWS Premier Tier partner, to build a new AWS-native platform.
• Project targets faster commercialization, improved scalability, stronger security, higher performance for enterprise deployments.
• Caylent will rebuild the platform rather than migrate the existing application, preserving core functionality while enabling future product development.
• Engagement structured to align with AWS funding programs, with funding support expected from AWS and Caylent.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Silo Pharma Inc. published the original content used to generate this news brief on August 06, 2026, and is solely responsible for the information contained therein.